Navigation Links
Springer adds Advances in Therapy to journals portfolio
Date:10/31/2007

As part of its continued commitment to providing high-quality information to professionals in the pharmaceutical industry, Springer has acquired the prestigious journal Advances in Therapy, to be published from 2008. With this move, Springer further enhances its services for clients in the pharmaceutical, healthcare and biotechnology industries.

Advances in Therapy, to be published by Springer Healthcare Communications (SHC), will continue to publish original research from the academic and research community across the globe as well as drug reviews and commissioned articles. Now in its 24th year of publication, the journal is Medline Indexed and has a strong Impact Factor, listed in both the ISI subject categories Pharmacology and Pharmacy and Medicine, Research and Experimental. The first issue of Advances in Therapy published by SHC will be Volume 25, No. 1, 2008.

The key feature of Advances in Therapy is the rapid publication of original research. Continuing this practice, SHC will increase its already rapid publication times to ensure online availability through SpringerLink within six weeks of submission. From 2008, Advances in Therapy will double its publication frequency from bimonthly to monthly.

Stephen Entwistle, Vice President of SHC, said, Advances in Therapy works closely with pharmaceutical researchers to deliver clinically important results to the academic and industrial community. I am very proud that the journal is now part of the Springer family and I am confident that the journals inclusion on SpringerLink will speed dissemination of important research worldwide.


'/>"/>
Contact: Renate Bayaz
renate.bayaz@springer.com
49-622-148-78531
Springer
Source:Eurekalert

Page: 1

Related medicine news :

1. Springer slated to spring a journal on Brain Imaging and Behavior
2. Advances in Treatment of Cataracts
3. Advances In Stem Cells Research
4. Speedier Access To Advances In Breast Cancer Sought For Patients
5. New Screening Techniques to Lead Advances In Pain Therapy
6. Advances Have Cut Combat Deaths in Iraq and Afghanistan
7. Prematurity More Accurately Predicted by Advances in Proteomic Technology
8. New DNA Tests Advances Treatment of Lysosomal Storage Diseases
9. Significant Advances in VCJD Prion Detection
10. Cancer Doctors Okays Controversial Prostate Therapy
11. Consensus on "Combination Therapy" for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... (PRWEB) , ... May 26, 2017 , ... A May ... who visit a doctor for colds or respiratory issues that are not responsive to ... time pressure on doctors may be largely responsible for the problem both in Canada ...
(Date:5/27/2017)... ... 27, 2017 , ... From May 21-23, hearing healthcare professionals gained a competitive ... at the Marriott Syracuse Downtown Hotel in Syracuse, New York. , As EarQ’s ... hearing healthcare providers to help them stay ahead in the industry. At the event, ...
(Date:5/26/2017)... ... May 26, 2017 , ... The ... to review more than eighty-nine grant submissions all vying for nearly $1,000,000 in ... the Parkinson’s field.     , The American Parkinson Disease Association (APDA) is focused on ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Amir Qureshi, ... System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS System ... “We are pleased to be the first in Arkansas to introduce the most powerful ...
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... , May 17, 2017  Bayer announced today that ... will be presented at the 53 rd Annual ... taking place June 2-6 in Chicago ... ASCO span prostate, colorectal, liver and thyroid cancers, as ... the Phase II CHRONOS-1 trial of copanlisib in patients ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: